| REGENERON PHARMACEUTICALS, INC. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | ||
| Fiscal Period | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | Q4-FY2013 | ||
| Operating Cash Flow | 1,144,400,000$ | 1,045,100,000$ | 1,262,800,000$ | 1,291,200,000$ | 354,000,000$ | 1,512,500,000$ | 1,089,700,000$ | 1,114,300,000$ | 1,022,400,000$ | 1,367,600,000$ | 1,719,900,000$ | 628,900,000$ | 564,400,000$ | 2,101,700,000$ | 2,372,500,000$ | 3,413,600,000$ | 626,700,000$ | 668,500,000$ | 1,231,000,000$ | (254,300,000$) | 943,400,000$ | 698,000,000$ | 787,400,000$ | 557,300,000$ | 188,300,000$ | 897,000,000$ | 728,800,000$ | 452,900,000$ | 394,600,000$ | 618,800,000$ | 566,937,000$ | 414,832,000$ | (30,570,000$) | 355,901,000$ | 390,383,000$ | 651,029,000$ | 415,148,000$ | 44,989,000$ | 281,823,000$ | 892,853,000$ | 243,606,000$ | (101,727,000$) | 198,175,000$ | 164,321,000$ | 336,412,000$ | 53,527,000$ | 281,729,000$ | ||
| Investing Cash Flow | (1,094,000,000$) | 647,500,000$ | 350,600,000$ | (574,400,000$) | (557,200,000$) | (1,687,100,000$) | (66,200,000$) | (496,300,000$) | (2,386,900,000$) | (235,700,000$) | (1,857,700,000$) | 192,300,000$ | (413,900,000$) | (1,705,300,000$) | (2,012,700,000$) | (2,438,800,000$) | 125,800,000$ | (1,059,000,000$) | (305,000,000$) | (775,800,000$) | 1,453,400,000$ | (443,200,000$) | (208,700,000$) | (207,000,000$) | (836,000,000$) | (776,100,000$) | (265,900,000$) | (286,700,000$) | (485,000,000$) | (425,400,000$) | (335,764,000$) | (358,884,000$) | (170,409,000$) | (140,143,000$) | (271,252,000$) | (405,853,000$) | (326,010,000$) | (43,685,000$) | (123,300,000$) | (283,171,000$) | (371,649,000$) | (129,481,000$) | 56,645,000$ | (123,068,000$) | (118,123,000$) | (236,231,000$) | (109,948,000$) | ||
| Financing Cash Flow | (1,128,200,000$) | (1,089,200,000$) | (1,135,500,000$) | (634,000,000$) | (478,100,000$) | 47,100,000$ | (446,100,000$) | (407,300,000$) | (614,200,000$) | (322,500,000$) | (247,600,000$) | (725,000,000$) | (101,100,000$) | 64,700,000$ | (906,600,000$) | 385,400,000$ | (118,200,000$) | (366,400,000$) | (305,300,000$) | 612,000,000$ | (2,612,800,000$) | 335,600,000$ | (345,700,000$) | (11,000,000$) | (15,300,000$) | 119,900,000$ | (83,000,000$) | 3,700,000$ | (11,200,000$) | 13,400,000$ | (210,535,000$) | (8,196,000$) | 133,519,000$ | 60,812,000$ | (491,788,000$) | 28,675,000$ | (46,844,000$) | (206,192,000$) | (4,008,000$) | (345,649,000$) | 10,690,000$ | 90,396,000$ | (252,655,000$) | 5,166,000$ | (80,012,000$) | 108,954,000$ | 100,616,000$ | ||
| End Cash Position | 1,995,800,000$ | 3,090,200,000$ | 2,488,200,000$ | 2,011,800,000$ | 1,920,700,000$ | 2,602,000,000$ | 2,730,000,000$ | 2,152,300,000$ | 1,937,200,000$ | 3,916,300,000$ | 3,105,900,000$ | 3,491,300,000$ | 3,395,100,000$ | 3,345,700,000$ | 2,885,600,000$ | 3,432,400,000$ | 2,072,200,000$ | 1,437,900,000$ | 2,193,700,000$ | 1,573,000,000$ | 1,992,200,000$ | 2,208,200,000$ | 1,617,800,000$ | 1,384,800,000$ | 1,045,500,000$ | 1,708,500,000$ | 1,467,700,000$ | 1,087,800,000$ | 917,900,000$ | 1,019,500,000$ | 812,700,000$ | 792,065,000$ | 744,313,000$ | 811,773,000$ | 535,200,000$ | 920,359,000$ | 646,508,000$ | 604,214,000$ | 809,102,000$ | 654,587,000$ | 390,554,000$ | 507,907,000$ | 648,719,000$ | 646,554,000$ | 600,135,000$ | 461,858,000$ | 535,608,000$ | ||
| Exchange Rate Effect | 400,000$ | 600,000$ | (300,000$) | (500,000$) | 200,000$ | (200,000$) | |||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | 92,600,000$ | 93,800,000$ | |||||||||||||||||||||||||||||||||||||||||||||||